Huang, Huocong
The University of Texas Southwestern Medical Center
6 papers on CoChatORCID 0000-0002-6345-4566
Most cited papers
- Verified
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
Huang, H., Wang, Z., Zhang, Y., Pradhan, R. N., Ganguly, D., Chandra, R., Murimwa, G., Wright, S., Gu, X., Maddipati, R., et al. (2022) · Cancer Cell
Pancreatic and Hepatic Oncology ResearchCancer Immunotherapy and Biomarkers
Cited by 542
- Verified
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
Hosein, A. N., Huang, H., Wang, Z., Parmar, K., Du, W., Huang, J., Maitra, A., Olson, E., Verma, U., & Brekken, R. A. (2019) · JCI Insight
Pancreatic and Hepatic Oncology ResearchSingle-cell and spatial transcriptomics
Cited by 302
- Verified
Preclinical assessment of galunisertib (LY2157299 monohydrate), a first‐in‐class transforming growth factor‐β receptor type I inhibitor
Yingling, J. M., McMillen, W. T., Yan, L., Huang, H., Sawyer, J. S., Graff, J., Clawson, D. K., Britt, K. S., Anderson, B. D., Beight, D. W., et al. (2018) · Oncotarget
TGF-β signaling in diseasesMechanisms of cancer metastasis
Cited by 187
- Verified
Inhibition of discoidin domain Receptor 1 reduces collagen-mediated tumorigenicity in pancreatic ductal adenocarcinoma
Aguilera, K. Y., Huang, H., Du, W., Hagopian, M. M., Wang, Z., Hinz, S., Hwang, T. H., Wang, H., Fleming, J. B., Castrillon, D. H., et al. (2017) · Molecular Cancer Therapeutics
Pancreatic and Hepatic Oncology ResearchProtease and Inhibitor Mechanisms
Cited by 118
- Verified
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
Huang, H., Zhang, Y., Gallegos, V., Sorrelle, N., Zaid, M. M., Toombs, J., Du, W., Wright, S., Hagopian, M., Wang, Z., et al. (2019) · EMBO Molecular Medicine
TGF-β signaling in diseasesPancreatic and Hepatic Oncology Research
Cited by 87
- Verified
SRC at the Crossroads of KRAS Inhibitor Resistance: Mechanisms and Therapeutic Opportunities
Tian, H., Zhao, D., Zhou, Z., Kim, A., Huang, H., Lee, Y. J., Qu, Z., Kang, R., Zeh, H. J., Westover, K. D., et al. (2026) · Cancer Letters
Protein Kinase Regulation and GTPase SignalingLung Cancer Treatments and Mutations
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free